Background Trauma represents an important public health concern in the United Kingdom, yet the acute costs of blunt trauma injury have not been documented and analysed in detail. Knowledge of the overall costs of trauma care, and the drivers of these costs, is a prerequisite for a cost-conscious approach to improvement in standards of trauma care, including evaluation of the cost-effectiveness of new healthcare technologies.
Introduction
Severe injury remains a common cause of death and permanent disability across all ages in the United Kingdom, and implies substantial costs to society in medical care, premature death, disability and use of social services [1, 2] . Injuries are a major cause of morbidity and mortality in young people, representing the leading cause of death in those aged younger than 35 years and causing approximately 3,500 deaths annually in England and Wales [3] . The number of serious injuries implies approximately 640,000 hospitals admissions each year and more than 6 million attendances to accident and emergency (A&E) departments [4, 5] .
The incidence of polytrauma (defined as an injury severity score (ISS) > 15) is currently 10,500 per year, equivalent to one patient per 1,000 presenting in A&E departments [6] . While the number of people killed or severely injured in a road traffic collision (RTC) has declined significantly over the past four decades, the numbers are still substantial: in 2005 there were 2,913 fatal road accidents, 25,029 serious road accidents and 170,793 minor road accidents in the United A&E = accident and emergency; AIS = Abbreviated Injury Scale; ISS = Injury Severity Score; NHS = National Health Service; RTC = road traffic collision; SD = standard deviation; TARN = Trauma Audit Research Network.
Kingdom [7] . The value to society of preventing these accidents was estimated at £12,807 million, or £64,440 per accident [8] . The annual cost to the National Health Service (NHS) of treating trauma injuries is currently estimated at £1.6 billion; about 7% of the total annual NHS budget [2] .
In light of the clinical and economic consequences of severe injury, the Royal College of Surgeons and the British Orthopaedic Association recommend developing a national system of trauma services based on the geographic trauma systems for England, Wales and Northern Ireland [1] . In addition, they recommend specific standards in trauma care for initial assessment and resuscitation, anaesthesia, intensive care and rehabilitation to provide hospital trusts with reasonable goals to which they could audit current clinical practice. Both organisations argue that improvement of care for the severely injured will create an opportunity for reducing the costs of avoidable death and unnecessary morbidity.
Recommendations for improving standards of care are likely to require additional funding and resources, raising questions about the cost-effectiveness of such healthcare improvements. While the outcomes of severe injury have been well documented over the past two decades and some information exists on the standards of trauma care, there are little data on the medical costs of severe injury in the United Kingdom. In particular, there is no information on the major determinants of hospital costs; for example, types of injuries and patient characteristics that drive the total costs of trauma care. Such information would usefully contribute to policy decision-making by targeting high-cost components in trauma care. It would also be a useful resource for evaluating the cost-effectiveness of trauma care interventions.
The aim of the present paper is to analyse the determinants of the costs of trauma care in England and Wales. We examine recent data on acute hospital treatment for blunt trauma and we estimate the acute hospital costs from the perspective of the NHS. We also identify the most important predictors of acute care costs in terms of patient and injury characteristics.
Methods

Data and variables
Data for this study were obtained from the Trauma Audit Research Network (TARN). Data from TARN have been used to examine a range of topics in trauma and trauma care, including trends in trauma care [9] , the effect of neurosurgical care on head injury outcome [10] , and outcome prediction in trauma [11] . The present study is the first to use TARN data to investigate the acute treatment costs of blunt trauma patients.
The TARN registry includes 50% of all hospitals receiving trauma patients in England and Wales [12] . The registry collects data on patients who sustain injuries resulting in immediate admission to hospital for ≥ 3 days, admission to an intensive care unit or a high dependency unit, or death within 93 days. Patients over 65 years old with isolated fracture of the neck of femur/pubic ramus and those with simple isolated injuries are excluded.
Data for this study came exclusively from the TARN database without author access to patient records. The TARN database is supported by the Healthcare Commission. Specific informed patient consent or ethical approval is not required because no patient identifiers are retained by TARN electronically or on paper. The TARN has Patient Information Advisory Group approval.
We included all patients hospitalised for blunt trauma in TARN hospitals between 1 January 2000 and 31 December 2005. Each hospital completes for every patient a data entry sheet with information on age, gender, cause and type of injuries, severity of injuries, treatment provided at the scene of incident, treatment en route to hospital, treatment in the A&E department, and any other care received at the hospital, including diagnostic tests, surgical procedures, and length of stay. Records of patients transferred between hospitals are linked so that full data for these patients are available.
In our study, injury severity is measured using the Injury Severity Score (ISS) [13] . The ISS is based on an ordinal scale ranging from 0 to 75, which is in turn based on the Abbreviated Injury Scale (AIS). Each AIS injury code is allocated an AIS score ranging from 1 (minor injury) to 6 (virtually unsurvivable injury). To compute the ISS, AIS injury codes are grouped into six body regions (head or neck, face, chest, abdominal or pelvic, extremities, and external) and the ISS is calculated as the sum of the squares of the highest AIS scores for the three most severely injured body regions. AIS codes of 6 are automatically allocated an ISS of 75. As no definitive grouping of ISS scores exists [14] , we used the following categories: ISS 0-9 group, ISS 10-16 group, ISS 17-25 group and ISS 26-75 group. This stratification allows one injury with an AIS score of 3 in the first category, one injury with an AIS score of 4 in the second category, and one injury with an AIS score of 5 in the third category. In addition, we used data on gender, age, cause of injury, earliest recorded Glasgow Coma Score (GCS), type and number of injuries sustained, discharge status, and year of admission.
We also used data from the TARN registry on the characteristics of the treatment received. These data included the mode of arrival at the hospital, the time from the emergency call to arrival at the A&E department (when by ambulance), the highest grade and specialty of the doctor attending the patient in the A&E department, the time spent in the A&E department, surgery, admission to critical care, and the length of stay. We also used data on whether or not the treating hospital had a neurosurgical centre and/or a spinal injury unit as a rough indicator of specialisation in trauma care. We excluded from the (page number not for citation purposes) analysis patients younger than 18 years of age at the time of injury.
Measuring costs
To estimate costs we took the perspective of the NHS in England and Wales; that is, only costs to the NHS in these regions were considered. We focused on the costs of the treatment received during the initial acute hospitalisation. We calculated treatment costs for each patient based on the following cost components: cost of transportation (ambulance, helicopter), cost of hospital stay (A&E department, critical care, general ward), and cost of all surgical procedures performed. Resource use for every component was recorded for each patient in the TARN database using the data entry sheet. For all resource use we assigned unit costs obtained from external sources to each item (see Table 1 ). All costs were measured in 2004 UK sterling.
Analysis
We first examined the demographic and clinical characteristics of the study sample and the acute treatment provided across groups of patients stratified by ISS. We then computed To identify significant independent determinants of acute treatment costs we undertook multivariate regression analysis. We regressed individual-level treatment costs against patient, injury and treatment characteristics. We excluded the variables used in the construction of the treatment cost variable. The variables included in the final regression model were selected using forward stepwise and backward stepwise selection procedures, where the significance level for removal from the model was P ≥ 0.01 and the significance level for addition to the model was P < 0.005. We also included 43 hospital indicators denoting the hospital at which the patient was treated. By including these indicators we aimed to control for variations in costs that are due to variations in provider practice rather than due to injury type, severity, and general treatment patterns. We report robust standard errors that control for clustering within individuals. The model is estimated using least squares and the coefficients are marginal effects.
Some of the data collected by the TARN registry and used in the present analysis are missing in a number of patients. The main variables with missing information are the time from emergency call to arrival at the A&E department and the surgical procedures. The latter may be missing because the relevant section on the data entry sheet completed by TARN participants describing the operative procedures is completed by free text and may have been left blank. We report the numbers of observations used to calculate every statistic reported. When we calculated the acute care costs for each patient, we did so using only patients with complete data. If data for one or more of the cost components were missing for a patient we assigned a 'missing' code to the total costs incurred by that patient, and we did not include the patient in the cost calculation.
Results
Patient and injury characteristics
We identified 35,564 patients with blunt injuries (blunt injury, nonpenetrating trauma or blunt force trauma) in the study period (Table 2) . Sixty percent had an ISS of 0 to 9 (21,280 patients), 17% had an ISS of 10 to 16 (6,075 patients), 12% had an ISS of 17 to 25 (4,375 patients), and 11% had an ISS of 26 to 75 (3,834 patients). Sixty-three percent of the sample was male, and the median age was 46 years (interquartile range 31 to 63 years). There was a higher than average proportion of males in the ISS 10-16 group, the ISS 17-25 group and the ISS 26-75 group, and the median age was lower in these groups.
Across all patients the most common cause of injury was falls (50%), followed by RTC (33%); RTC was the most common cause of injury among patients with an ISS of 10 to 75. The median Glasgow Coma Score was 15 (interquartile range 15 to 15) across the whole sample, but was only 10 (interquartile range 4 to 15) in the ISS 26-75 group. The most common serious injuries (with AIS ≥ 3) were injuries to the lower limbs (40%), the head (20%), the upper limbs (18%) and the chest (13%). The average patient sustained 1.5 injuries with an AIS score ≥ 3, ranging from 0.8 in the ISS 0-9 group to 4.4 in the ISS 26-75 group. Seven percent of patients died in hospital, with the highest proportion of deaths among those in the ISS 26-75 group (32%). Of the hospital deaths observed, the mean (standard deviation (SD)) time to death was 9.3 days (20.3 days) from the date of arrival at the hospital. The time to death was 7.5 days (21.7 days) for RTC, 7.6 days (17.1 days) for falls more than 2 metres, 14.4 days (19.7 days) for falls less than 2 meters, and 5.6 days (9.3 days) for blows.
Treatment characteristics
Eighty percent of the patients arrived at the hospital by ambulance, 11% by car, and 6% by helicopter ( Table 3 ). The mean (SD) time from emergency call to arrival at the A&E department was 71 minutes (95 min), and the mean (SD) time in the A&E department was 194 minutes (155 min). Fifteen percent of patients were seen by a consultant in the A&E department, 42% were seen by a middle-grade doctor and 39% were seen by a senior house officer. The proportion seeing a consultant was highest (32%) in the most severely injured group of patients (ISS 26-75 group). Seventy-four percent of patients were seen by a doctor specialising in emergency medicine; attending specialists in orthopaedics (42%), anaesthesia (13%), neurosurgery (10%), and general surgery (9%) were also common.
Sixty nine percent of patients underwent at least one surgical procedure; the most common were bone fixation (47%), wound debridement (6%) and intracranial procedures (6%). Open reduction and internal fixation was the most common procedure in the ISS 0-9 group, the ISS 10-16 group and the ISS 17-25 group (35%, 19% and 10% of patients, respectively). Evacuation of extradural haematoma/subdural haematoma was the most common procedure in the ISS 26-75 group (9%).
Twenty-nine percent of patients were admitted to critical care. The percentage ranged from 10% in the ISS 0-9 group to 79% in the ISS 26-75 group. It is noteworthy that the percentage of patients in the ISS 26-75 group admitted to critical care was less than 100%. This finding may be explained by an insufficient number of critical care beds available to meet the demand. The median length of stay in critical care among those who were admitted was 4 days (interquartile range 2 to 10 days). As expected, the median length of stay in critical care was shortest in the ISS 0-9 group (2 days, interquartile range 1 to 5 days) and longest in the ISS 26-75 group (7 days, interquartile range 3 to 15 days). The median total length of stay, including the length of stay on a general ward and in critical care, was 9 days (interquartile range 5 to 19 days) across the whole sample -ranging from 8 days (interquartile range 5 to 14 days) in the ISS 0-9 group to 17 days (interquartile range 6 to 39 days) in the ISS 26-75 group.
Fifty-two percent of patients were treated in a hospital with a neurosurgical centre, and 6% of patients were treated in a hospital with a spinal injuries unit.
Treatment costs
The mean (SD) total hospital cost per patient was £9,530 (± 11,872) ( Table 4) . Across all patients, the length of stay in a general ward accounted for the largest percentage of costs (46%), followed by the length of stay in critical care (29%). The next most important component was surgical procedures (15%), followed by travel to the A&E department (5%) and A&E costs (4%). These proportions were not the same for every ISS group: for patients in the ISS 17-25 and the ISS 26-75 groups the length of stay in critical care was the largest component of cost, accounting for 42% and 52% of the mean total costs, respectively. Mean costs increased with ISS up to a mean cost of £21,173 in the ISS 26-75 group. Sample size is equal to the total number other than where indicated by n. a Injuries with an Abbreviated Injury Scale score ≥ 3. There was little impact of gender on costs, but costs increased with age in the ISS 0-9 group and the ISS 10-16 group, and decreased in the elderly in the other ISS groups; this age effect is possibly associated with a higher mortality in the elderly. Treatment costs were highest among patients injured in a RTC, and among patients in coma upon arrival at the hospital (Glasgow Coma Score ≤ 8). Every type of serious injury was associated with higher treatment costs; limb injuries had the smallest additional impact on cost, and abdominal injuries had the largest additional impact. Treatment costs increased with the number of serious injuries sustained by the patient.
In the ISS 0-9 group and the ISS 10-16 group, mortality was associated with higher treatment costs compared with being alive at discharge. Conversely, mortality was associated with lower treatment costs in the ISS 17-25 group and the ISS 26-75 group. Across all patients, mortality implied a slight increase in treatment costs.
The impact of treatment patterns on treatment costs are presented in Table 5 . Treatment costs varied by mode of hospital arrival (helicopter is the most expensive, followed by ambulance) and the time from emergency call to arrival at the A&E department (both positively correlated), and by the time in the A&E department (negatively correlated). Mean treatment costs were higher if the patient was seen by a consultant, and if the patient was seen by a doctor from the specialties of anaesthesia, neurosurgery and general surgery. Since the unit costs used in the analysis do not vary by the grade or specialty of the doctors seen in the A&E department, the observed variation in costs by the type of doctor relate to variations in surgery and length of stay, which in turn are affected by injury severity. Patients who were seen by a consultant had more severe injuries than those who were seen by less senior medical personnel, which probably explains the higher costs incurred by this group (mean ISS 17.8 versus 12.0, mean difference 5.8, 95%
confidence interval 5.5 to 6.2). Patients treated by doctors from anaesthesia, neurosurgery and general surgery were also more severely injured than those who did not see doctors from these specialties (mean ISS 20.6 versus 10.5, mean difference 10.1, 95% confidence interval 9.8 to 10.3).
Surgery for bone fixation was associated with higher treatment costs among patients in some, but not all, ISS groups. Wound debridement and intracranial procedures were associated with higher mean costs in all ISS groups.
As expected, treatment costs were positively correlated with the length of stay -both for critical care length of stay and for total length of stay. Mean treatment costs did not vary by whether or not the hospital in which the patient was treated had either a neurosurgical centre or a spinal injuries unit.
Multivariate analysis
The results of the multivariate regression analysis of costs are presented in Table 6 . The covariates explain 28% of the variation in hospital costs. The most significant determinants of costs were ISS and age (both positively correlated with costs), RTC (significantly higher costs than other causes), and Glasgow Coma Score (negatively correlated with costs, indicating greater severity was associated with higher costs). Serious injuries of the abdomen, thorax, spine and upper and lower limbs were significantly associated with higher treatment costs, while hospital mortality was significantly associated with lower treatment costs. Being seen in the A&E department by a consultant or middle-grade doctor was associated with significantly higher costs than being seen by a senior house officer, and being seen by a doctor from the specialties of anaesthesia or general surgery was also associated with a significant increase in treatment cost. 
Discussion
This study provides the first detailed description of the demographic and clinical characteristics of blunt trauma patients in England and Wales, their causes of injury, the acute treatment received and outcomes. The present study is the first to provide a detailed assessment of the NHS hospital costs associated with blunt trauma in England and Wales. The average blunt trauma patient was male, 46 years old, injured by a fall, with an ISS in the range 0 to 9. The most frequent serious injuries were to the upper and lower limbs, head and chest. Around 30% of all blunt trauma patients were admitted to critical care for a median of 4 days. The total median hospital length of stay was 9 days; 7% of the patients died before hospital discharge. The average cost of acute treatment to the NHS was £9,500 per patient.
Few studies have been published on the cost of acute treatment for blunt trauma in the United Kingdom; hence it is difficult to assess the robustness of our cost estimates. In one study, Sikand and colleagues examined the cost implications of treating 69 polytrauma patients (defined as ISS > 15) admitted to an English university hospital in 2000 [15] . The authors reported an average cost of acute care of £14,129 per patient. In our study the costs per patient with ISS > 15 are slightly higher at £16,776; presumably the small difference is explained mainly by changes in NHS pay and prices over time.
Our results suggest that influential determinants of cost were the cause of injury (especially falls and RTCs) and the age of the patient. This influence emphasises the importance of continued public health education and accident prevention measures. From the hospital perspective, the most important cost drivers are length of stay in critical care and total hospital length of stay, accounting for 75% of total costs and far exceeding other components such as transport to hospital, immediate resuscitation in the A&E department, and trauma surgery. In the hospital setting, this suggests that steps to reduce the hospital length of stay (such as expeditious surgery, reduced discharge delays from critical care, outreach services support and earlier placement on a rehabilitation programme) are likely to be more effective, all else equal, than other measures aimed at reducing the costs of blunt trauma care.
The year of admission was a significant predictor of costs, with lower mean treatment costs in the latter part of our study. This may be due to changes in the NHS costs over the period 2000 to 2005, or to improvement in the hospital care pathways introduced to enhance the cost-effectiveness of trauma care; however, the time series is too short to be able to draw any firm conclusions.
We chose to examine the costs of blunt trauma because, in the United Kingdom, this is the largest group of trauma patients -representing 98% of patients in the TARN registry. Any interventions directed at blunt trauma victims or improvements in the care of blunt trauma victims are therefore likely to have the largest public health benefit.
Since 1994 the Department for Transport in England has published annual costs estimates for road casualties for use in cost-benefit analyses of road safety schemes. The latest estimates of the medical and ambulance costs associated with slight, serious and fatal injuries from road traffic collisions in 2005 were £850, £11,460 and £840, respectively [8] . The mean medical and ambulance costs across all casualties were £1,980. These cost estimates represent figures updated from a 1994 study and are significantly lower than the costs observed in our study: the mean costs per person injured in a road traffic collision were £12,800, ranging from £7,200 for the least severely injured to £23,000 for the most severely injured patients. The mean treatment costs in our study among those who died in a RTC were £12,000. If the Department of Transport figures underestimate the true costs of road trauma then they are likely to underestimate the value of potential road safety schemes. The cost estimates generated in our study are likely to be biased upwards because they exclude patients who died before they reached the hospital, and exclude patients hospitalised for less than 3 days and without admis- sion to an intensive care unit/high dependency unit. Both of these patient groups would probably have incurred lower hospital costs than those in our study. Nonetheless, our figures suggest that the cost estimates used by the Department of Transport should be updated.
The mortality rate observed in the current study (7%) suggests that no improvement in survival after blunt trauma has occurred over the past decade in England and Wales. In the most recent assessment among 129,979 blunt trauma patients admitted to hospital between 1989 and 2000, the in-hospital mortality rate was 5.6% among patients with a complete revised trauma score (107,282 patients) and 7.4% among those with an incomplete revised trauma score (46,949 patients) [9] . The authors of the study reported a decline in the severity adjusted odds of death of 3% per year since 1989, although much of the reduction occurred between 1989 and 1994.
We acknowledge a number of limitations to our study. First, we did not include treatment cost occurring after the initial hospitalisation period, including the costs of rehabilitation, home care support and any subsequent hospitalisations related to blunt trauma.
Second, the retrospective nature of the study implies reliance on the quality and completeness of the data reported to the TARN registry. We observed incomplete data on a number of important treatment parameters, particularly the time from emergency call to arrival at the A&E department and surgical procedures. If these data, particularly those relating to surgical procedures, are not missing at random across the recorded patient characteristics, then our results could be biased.
Third, we excluded patients who were admitted for fewer than 3 days and who died before they reached the hospital. Those patients who were not admitted and those who died will have incurred lower treatment costs than those who were admitted, and therefore our estimates are likely to have overestimated the costs of blunt trauma care. Since those who were not admitted are likely to be less severely injured than those patients who were admitted, the extent of the overestimation is likely to be higher for those in the less severely injured ISS groups.
Fourth, the indirect costs related to lost productivity and time spent away from other activities, as well as the costs associated with the pain and suffering by victims and relatives, were not included. The cost of follow-up care and the indirect costs can be substantial, and are likely to represent the majority of the lifetime societal costs of blunt trauma.
Finally, the unit costs used in the analysis are, by necessity, crude. In particular, the unit costs of hospital stays are not specific to blunt trauma patients. Clearly it would have been more appropriate to use the actual costs incurred by each trauma patient included in the analysis, yet these data were not available for our study.
Conclusion
In this study we provide the first detailed information on treatment patterns, mortality and costs of blunt trauma in the acute care setting in England and Wales. Our findings indicate that the initial hospital costs associated with blunt trauma vary significantly by patient characteristics, by injury characteristics and by treatment characteristics. The largest component of treatment cost, however, is determined by the total hospital 
